- Home
- Publications
- Publication Search
- Publication Details
Title
NK Cell-Based Glioblastoma Immunotherapy
Authors
Keywords
-
Journal
Cancers
Volume 10, Issue 12, Pages 522
Publisher
MDPI AG
Online
2018-12-18
DOI
10.3390/cancers10120522
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor
- (2018) Alexander D. Barrow et al. CELL
- Tumor treating fields: a new approach to glioblastoma therapy
- (2018) Jonathan Rick et al. JOURNAL OF NEURO-ONCOLOGY
- Multidimensional communication in the microenvirons of glioblastoma
- (2018) Marike L. Broekman et al. Nature Reviews Neurology
- Metastatic Brain Tumors Disrupt the Blood-Brain Barrier and Alter Lipid Metabolism by Inhibiting Expression of the Endothelial Cell Fatty Acid Transporter Mfsd2a
- (2018) Shweta Tiwary et al. Scientific Reports
- Impedance-based analysis of Natural Killer cell stimulation
- (2018) Frank Fasbender et al. Scientific Reports
- Advances in Glioblastoma Multiforme Treatment: New Models for Nanoparticle Therapy
- (2018) Elif Ozdemir-Kaynak et al. Frontiers in Physiology
- Targeting and Therapy of Glioblastoma in a Mouse Model Using Exosomes Derived From Natural Killer Cells
- (2018) Liya Zhu et al. Frontiers in Immunology
- Glioblastoma Stem-Like Cells Are More Susceptible Than Differentiated Cells to Natural Killer Cell Lysis Mediated Through Killer Immunoglobulin-Like Receptors–Human Leukocyte Antigen Ligand Mismatch and Activation Receptor–Ligand Interactions
- (2018) Heleen Neeltje Haspels et al. Frontiers in Immunology
- Novel Human NK Cell Line Carrying CAR Targeting EGFRvIII Induces Antitumor Effects in Glioblastoma Cells
- (2018) TOSHIHARU MURAKAMI et al. ANTICANCER RESEARCH
- Natural killer cells induce distinct modes of cancer cell death: Discrimination, quantification and modulation of apoptosis, necrosis and mixed forms
- (2018) Christian S Backes et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Microglia/Astrocytes–Glioblastoma Crosstalk: Crucial Molecular Mechanisms and Microenvironmental Factors
- (2018) Diana Matias et al. Frontiers in Cellular Neuroscience
- Novel alternatives to extracellular vesicle-based immunotherapy – exosome mimetics derived from natural killer cells
- (2018) Liya Zhu et al. Artificial Cells Nanomedicine and Biotechnology
- Blockade of CCR5 receptor prevents M2 microglia phenotype in a microglia-glioma paradigm
- (2017) Emilia Laudati et al. NEUROCHEMISTRY INTERNATIONAL
- Exosomes Derived From Natural Killer Cells Exert Therapeutic Effect in Melanoma
- (2017) Liya Zhu et al. Theranostics
- Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity
- (2017) Congcong Zhang et al. Frontiers in Immunology
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Cancer Immunotherapy for Gliomas: Overview and Future Directions
- (2016) Naoya HASHIMOTO NEUROLOGIA MEDICO-CHIRURGICA
- Human astrocytes secrete IL-6 to promote glioma migration and invasion through upregulation of cytomembrane MMP14
- (2016) Weiliang Chen et al. Oncotarget
- Immunological Evasion in Glioblastoma
- (2016) Roxana Magaña-Maldonado et al. Biomed Research International
- Human Circulating and Tissue-Resident CD56bright Natural Killer Cell Populations
- (2016) Janine E. Melsen et al. Frontiers in Immunology
- Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer
- (2016) John Pradeep Veluchamy et al. PLoS One
- Natural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain
- (2015) Se Jeong Lee et al. BMC CANCER
- RB mutation and RAS overexpression induce resistance to NK cell-mediated cytotoxicity in glioma cells
- (2015) Mario Orozco-Morales et al. Cancer Cell International
- Cytomegalovirus Infection Drives Adaptive Epigenetic Diversification of NK Cells with Altered Signaling and Effector Function
- (2015) Heinrich Schlums et al. IMMUNITY
- ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma
- (2015) Congcong Zhang et al. JNCI-Journal of the National Cancer Institute
- Revisiting the Mechanisms of CNS Immune Privilege
- (2015) Antoine Louveau et al. TRENDS IN IMMUNOLOGY
- Down-regulation of IKKβ expression in glioma-infiltrating microglia/macrophages is associated with defective inflammatory/immune gene responses in glioblastoma
- (2015) Jakub Mieczkowski et al. Oncotarget
- ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma
- (2015) Congcong Zhang et al. JNCI-Journal of the National Cancer Institute
- Present and Future of Allogeneic Natural Killer Cell Therapy
- (2015) Okjae Lim et al. Frontiers in Immunology
- Epidemiologic and Molecular Prognostic Review of Glioblastoma
- (2014) J. P. Thakkar et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Cell biological steps and checkpoints in accessing NK cell cytotoxicity
- (2014) Emily M Mace et al. IMMUNOLOGY AND CELL BIOLOGY
- NK Cells with KIR2DS2 Immunogenotype Have a Functional Activation Advantage To Efficiently Kill Glioblastoma and Prolong Animal Survival
- (2014) Andrea Gras Navarro et al. JOURNAL OF IMMUNOLOGY
- Molecular Heterogeneity of Glioblastoma and its Clinical Relevance
- (2014) Katalin Eder et al. PATHOLOGY & ONCOLOGY RESEARCH
- Combining NK cells and mAb9.2.27 to combat NG2-dependent and anti-inflammatory signals in glioblastoma
- (2014) Justyna Kmiecik et al. OncoImmunology
- Controlling Natural Killer Cell Responses: Integration of Signals for Activation and Inhibition
- (2013) Eric O. Long et al. Annual Review of Immunology
- NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17)
- (2013) R. Romee et al. BLOOD
- The relevance of the TGF-β Paradox to EMT-MET programs
- (2013) Chevaun D. Morrison et al. CANCER LETTERS
- Circulating T regulatory cells migration and phenotype in glioblastoma patients: an in vitro study
- (2013) Chiara Vasco et al. JOURNAL OF NEURO-ONCOLOGY
- Natural killer cells in intracranial neoplasms: presence and therapeutic efficacy against brain tumours
- (2013) Justyna Kmiecik et al. JOURNAL OF NEURO-ONCOLOGY
- Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level
- (2013) Justyna Kmiecik et al. JOURNAL OF NEUROIMMUNOLOGY
- Natural Killer Cell Mediated Antibody-Dependent Cellular Cytotoxicity in Tumor Immunotherapy with Therapeutic Antibodies
- (2013) Ursula J. E. Seidel et al. Frontiers in Immunology
- The natural killer cell response and tumor debulking are associated with prolonged survival in recurrent glioblastoma patients receiving dendritic cells loaded with autologous tumor lysates
- (2013) Serena Pellegatta et al. OncoImmunology
- Adoptive Cell Therapies for Glioblastoma
- (2013) Kevin Bielamowicz et al. Frontiers in Oncology
- Glioblastoma, a Brief Review of History, Molecular Genetics, Animal Models and Novel Therapeutic Strategies
- (2012) Sameer Agnihotri et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma
- (2012) D. M. Benson et al. BLOOD
- NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality
- (2012) Roger Stupp et al. EUROPEAN JOURNAL OF CANCER
- Soluble factors secreted by glioblastoma cell lines facilitate recruitment, survival, and expansion of regulatory T cells: implications for immunotherapy
- (2012) C. A. Crane et al. NEURO-ONCOLOGY
- Two modes of lytic granule fusion during degranulation by natural killer cells
- (2011) Dongfang Liu et al. IMMUNOLOGY AND CELL BIOLOGY
- Use of allogeneic NK cells for cancer immunotherapy
- (2011) Melissa A Geller et al. Immunotherapy
- Induction of In Vitro and In Vivo NK Cell Cytotoxicity Using High-Avidity Immunoligands Targeting Prostate-Specific Membrane Antigen in Prostate Carcinoma
- (2011) R. D. Jachimowicz et al. MOLECULAR CANCER THERAPEUTICS
- Cell Death Mechanisms Induced by Cytotoxic Lymphocytes
- (2010) L Chávez-Galán et al. Cellular & Molecular Immunology
- CX3CR1 promotes recruitment of human glioma-infiltrating microglia/macrophages (GIMs)
- (2010) Janka Held-Feindt et al. EXPERIMENTAL CELL RESEARCH
- Glioblastoma Cancer-Initiating Cells Inhibit T-Cell Proliferation and Effector Responses by the Signal Transducers and Activators of Transcription 3 Pathway
- (2010) J. Wei et al. MOLECULAR CANCER THERAPEUTICS
- Membrane nanotubes facilitate long-distance interactions between natural killer cells and target cells
- (2010) A. Chauveau et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Functional Anatomy of T Cell Activation and Synapse Formation
- (2009) David R. Fooksman et al. Annual Review of Immunology
- Natural killer cell cytotoxicity: how do they pull the trigger?
- (2009) Nicola J. Topham et al. IMMUNOLOGY
- NK Cells Recognize and Kill Human Glioblastoma Cells with Stem Cell-Like Properties
- (2009) R. Castriconi et al. JOURNAL OF IMMUNOLOGY
- Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial
- (2008) S. Arai et al. CYTOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started